Kevin Liaw

1.2k citations

30 papers · 761 indexed · h-index 16

Co-authors: Sujatha Kannan Rangaramanujam M. Kannan Rishi Sharma Anjali Sharma Zhi Zhang Michelle Chang R.L. McDaniels Fan Zhang
Topics: RNA Interference and Gene Delivery (9 papers)Dendrimers and Hyperbranched Polymers (7 papers)CAR-T cell therapy research (6 papers)
Cited by: Neurology Biomaterials Polymers and Plastics
Journals: SHILAP Revista de lepidopterologíaAdvanced Drug Delivery Reviews Journal of Controlled Release
Partner nations: United States Brazil China

In The Last Decade

Kevin Liaw

29 papers receiving 757 citations

Peers

Countries citing papers authored by Kevin Liaw

Since Specialization

Citations

This map shows the geographic impact of Kevin Liaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Liaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Liaw more than expected).

Fields of papers citing papers by Kevin Liaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Liaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Liaw. The network helps show where Kevin Liaw may publish in the future.

Co-authorship network of co-authors of Kevin Liaw

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Liaw. A scholar is included among the top collaborators of Kevin Liaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Liaw. Kevin Liaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPV 2025 ·Frontiers in Immunology ·(unknown),Xizhou Zhu,Pratik Bhojnagarwala,Kevin Liaw,Yun Gao,(unknown),(unknown),(unknown),(unknown),(unknown),Samuel E. Garfinkle,(unknown),David B. Weiner,Daniel W. Kulp	0
2	Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma 2024 ·Journal for ImmunoTherapy of Cancer ·Ryan P. O’Connell,Kevin Liaw,Nils Wellhausen,(unknown),Pratik Bhojnagarwala,Devivasha Bordoloi,Daniel H. Park,(unknown),Daniel W. Kulp,Carl H. June,David B. Weiner	6
3	Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells 2024 ·Journal for ImmunoTherapy of Cancer ·Daniel H. Park,Pratik Bhojnagarwala,Kevin Liaw,Devivasha Bordoloi,Nicholas J. Tursi,(unknown),Zev A. Binder,Donald M. O’Rourke,David B. Weiner	4
4	Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape 2023 ·Molecular Therapy — Oncolytics ·Daniel H. Park,Kevin Liaw,Pratik Bhojnagarwala,Xizhou Zhu,Jihae Choi,Ali Ali,Devivasha Bordoloi,E. Gary,Ryan P. O’Connell,Abhijeet J. Kulkarni,(unknown),Trevor R.F. Smith,Alfredo Perales‐Puchalt,Ami Patel,David B. Weiner	11
5	Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo 2023 ·Frontiers in Immunology ·Nicholas J. Tursi,Ziyang Xu,(unknown),Susanne N. Walker,Kevin Liaw,Neethu Chokkalingam,Toshitha Kannan,Yuanhan Wu,Edgar Tello‐Ruiz,Daniel H. Park,Xizhou Zhu,Megan C. Wise,Trevor R.F. Smith,Sonali Majumdar,Andrew V. Kossenkov,Daniel W. Kulp,David B. Weiner	3
6	A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy 2022 ·JCI Insight ·Devivasha Bordoloi,Pratik Bhojnagarwala,Alfredo Perales‐Puchalt,Abhijeet J. Kulkarni,Xizhou Zhu,Kevin Liaw,Ryan P. O’Connell,Daniel H. Park,Daniel W. Kulp,Rugang Zhang,David B. Weiner	14
7	Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis 2022 ·Neurotherapeutics ·Carolyn Tallon,Anjali Sharma,Zhi Zhang,Ajit G. Thomas,(unknown),Xiaolei Zhu,(unknown),M. Schulte,(unknown),Siva P. Kambhampati,Rishi Sharma,Kevin Liaw,Sujatha Kannan,Rangaramanujam M. Kannan,Barbara S. Slusher	15
8	In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme 2022 ·Molecular Therapy — Oncolytics ·Pratik Bhojnagarwala,Ryan P. O’Connell,Daniel Park,Kevin Liaw,Ali Ali,Devivasha Bordoloi,Joel Cassel,Nicholas J. Tursi,E. Gary,David B. Weiner	12
9	ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survival 2021 ·Science Advances ·Michael A. Harris,Huihui Kuang,Zachary Schneiderman,(unknown),Andrew Crane,Matthew R. Chrostek,Flaviu Tăbăran,Thomas Pengo,Kevin Liaw,Beibei Xu,Lucy Lin,Clark C. Chen,Maeve O’Sullivan,Rangaramanujam M. Kannan,Walter C. Low,Efrosini Kokkoli	19
10	DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas 2021 ·Molecular Therapy — Oncolytics ·Xizhou Zhu,Alfredo Perales‐Puchalt,(unknown),Ziyang Xu,(unknown),Pratik Bhojnagarwala,Devivasha Bordoloi,Daniel H. Park,Kevin Liaw,Mamadou A. Bah,Paul M. Lieberman,E. Gary,Ami Patel,David B. Weiner	5
11	Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma 2021 ·Journal of Controlled Release ·Rishi Sharma,Kevin Liaw,Anjali Sharma,(unknown),Michelle Chang,(unknown),(unknown),Sujatha Kannan,Rangaramanujam M. Kannan	76
12	Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis 2021 ·Nanotheranostics ·Kristen R. Hollinger,Anjali Sharma,Carolyn Tallon,(unknown),Ajit G. Thomas,Xiaolei Zhu,(unknown),Ying Wu,Siva P. Kambhampati,Kevin Liaw,Rishi Sharma,Camilo Rojas,Rana Rais,Sujatha Kannan,Rangaramanujam M. Kannan,Barbara S. Slusher	26
13	Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma 2020 ·Journal of Controlled Release ·Kevin Liaw,Rishi Sharma,Anjali Sharma,(unknown),(unknown),Rangaramanujam M. Kannan	36
14	Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration 2020 ·Bioengineering & Translational Medicine ·Kevin Liaw,Fan Zhang,Antonella Mangraviti,Sujatha Kannan,Betty Tyler,Rangaramanujam M. Kannan	52
15	Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma 2020 ·Bioengineering & Translational Medicine ·Kevin Liaw,Rajasekhar R. Ramireddy,Anjali Sharma,Jiangyu Li,Michelle Chang,Rishi Sharma,(unknown),Sujatha Kannan,Rangaramanujam M. Kannan	30
16	Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics 2018 ·Theranostics ·Anjali Sharma,Kevin Liaw,Rishi Sharma,Zhi Zhang,Sujatha Kannan,Rangaramanujam M. Kannan	128
17	Quantitative assessment of surface functionality effects on microglial uptake and retention of PAMAM dendrimers 2018 ·Journal of Nanoparticle Research ·Kevin Liaw,(unknown),(unknown),Sujatha Kannan,Rangaramanujam M. Kannan	19
18	Pick Up a Book or “Google It?” A Survey of Radiologist and Trainee-Preferred References and Resources 2013 ·Journal of Digital Imaging ·Blake D. Niederhauser,Kevin Liaw,Robert J. McDonald,Kristen B. Thomas,(unknown),David F. Kallmes	11
19	The clinical impact of the radiology report in wheezing and nonwheezing febrile children: a survey of clinicians 2009 ·Pediatric Radiology ·Stephanie E. Spottswood,Kevin Liaw,Marta Hernanz‐Schulman,Melissa A. Hilmes,Paul E. Moore,Barron L. Patterson,Heidi Chen,J. Herman Kan	12
20	Lipofibromatous hamartoma 2008 ·Pediatric Radiology ·Kevin Liaw,J. Herman Kan	8

About Kevin Liaw

Kevin Liaw is a scholar working on Health Informatics, Neurology and Immunology, having authored 30 papers that have together received 761 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Dendrimers and Hyperbranched Polymers (7 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Neurology (115 citations), Biomaterials (142 citations) and Polymers and Plastics (125 citations). Kevin Liaw has collaborated with scholars based in United States, Brazil and China. Frequent co-authors include Sujatha Kannan, Rangaramanujam M. Kannan, Rishi Sharma, Anjali Sharma, Zhi Zhang, Michelle Chang, R.L. McDaniels, Fan Zhang, Barbara S. Slusher and Antonella Mangraviti. Their work appears in journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact